ZNTL Earnings & Financial Statements - Zentalis Pharmaceuticals, Inc. logo

ZNTL Earnings & Financial Statements

Zentalis Pharmaceuticals, Inc.

$1.36
$0.00(0.00%)
37
Overall
60
Value
27
Tech
26
Quality
How is this score calculated?
Market Cap
$133.64M
Volume
1.46M
52W Range
$1.28 - $6.95
Target Price
$7.80

ZNTL earnings and financial statements: Zentalis Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

ZNTL Annual Financial Statements

ZNTL income statement
Fiscal year20252024202320222021
Revenue-$67.42M$900.0K--
Operating income-$145.01M-$191.19M-$299.51M-$227.29M-$216.54M
EBITDA-$144.27M-$164.39M-$291.51M-$236.18M-$216.00M
Net income-$137.06M-$165.84M-$292.19M-$236.81M-$158.72M
EPS (diluted)$-1.91$-2.33$-4.47$-4.48$-3.72
ZNTL balance sheet
Fiscal year20252024202320222021
Total assets$288.97M$430.34M$551.69M$539.31M$454.51M
Total liabilities$72.76M$93.15M$114.30M$105.29M$90.03M
Shareholders’ equity$216.20M$337.19M$437.28M$433.80M$363.95M
Cash and equivalents$35.99M$33.90M$28.04M$43.07M$59.71M
Long-term debt$35.70M$39.58M$43.15M$45.17M$44.46M
ZNTL cash flow statement
Fiscal year20252024202320222021
Operating cash flow-$125.25M-$170.86M-$207.82M-$163.75M-$154.09M
Capital expenditure$698.0K-$156.0K-$583.0K-$2.55M-$6.11M
Free cash flow-$125.25M-$171.08M-$208.41M-$166.30M-$160.20M
ABCD
1SymbolPriceChangeVol
2ZNTL$1.360%1.46M
3
4
5
6

Get Zentalis Pharmaceuticals, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.